NCT07334639

Brief Summary

This goal of the study is to assess the effect of weight gain in patients with achalasia after they are treated. The main question to be answered is if weight gain after achalasia treatment is associated with worsening metabolic status. Patients will be compared between their baseline status at the time of treatment and 1 year after treatment. Participants will have metabolic tests performed at these 2 times including blood tests.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
32mo left

Started Jan 2026

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Jan 2026Jan 2029

First Submitted

Initial submission to the registry

December 31, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 12, 2026

Completed
3 days until next milestone

Study Start

First participant enrolled

January 15, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

January 13, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

December 31, 2025

Last Update Submit

January 11, 2026

Conditions

Keywords

achalasiaweight gainobesitymetabolic syndromehepatic steatosis

Outcome Measures

Primary Outcomes (1)

  • Increase in Hepatic steatosis

    The degree of hepatic steatosis assessed on FibroScan at baseline compared to 1 year later

    1 year

Secondary Outcomes (10)

  • fasting glucose

    1 year

  • Hgb A1c

    1 year

  • Cholesterol

    1 year

  • Triglycerides

    1 year

  • Weight

    1 year

  • +5 more secondary outcomes

Study Arms (1)

Achalasia patients

Patients with achalasia who undergoing treatment with either per oral endoscopic myotomy (POEM) or laparoscopic Heller myotomy (LHM). Each participant's metabolic status will be evaluated at the time of treatment and one year later.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with achalasia and undergoing therapy with either POEM or LHM

You may qualify if:

  • Proven achalasia
  • Undergoing LHM or POEM for treatment

You may not qualify if:

  • Under age 18
  • Does no consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hadassah Medical Center

Jerusalem, Israel

Location

Shamir Medical Center

Ẕerifin, Israel

Location

Related Publications (2)

  • Patel DA, Vaezi MF. Achalasia and Nutrition: Is it Simple Physics or Biology. Pract Gastro. 2016 Nov;40(11):42-48.

    BACKGROUND
  • Pandolfino JE, Gawron AJ. Achalasia: a systematic review. JAMA. 2015 May 12;313(18):1841-52. doi: 10.1001/jama.2015.2996.

    PMID: 25965233BACKGROUND

MeSH Terms

Conditions

Esophageal AchalasiaWeight GainObesityMetabolic SyndromeFatty Liver

Condition Hierarchy (Ancestors)

Esophageal Motility DisordersDeglutition DisordersEsophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesBody Weight ChangesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesInsulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesLiver Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Gastroenterologist

Study Record Dates

First Submitted

December 31, 2025

First Posted

January 12, 2026

Study Start

January 15, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2029

Last Updated

January 13, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

The confidential information will only be used for this study.

Locations